14 results found.

Polyarticular-course Juvenile Idiopathic Arthritis (JIA) Clinical Trial using Certolizumab Pegol (CZP)

UCB, Inc. - Recruiting 2 years to 17 years.
- A Multicenter, Open-label Study to Assess the Pharmacokinetics, Safety and Efficacy of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Polyarticular-course Juvenile Idiopathic Arthritis (JIA).
Certolizumab Pegol (CZP)

Juvenile Idiopathic Arthritis Clinical Trial

Bristol-Myers Squibb - Recruiting N/A to 17 years.
- An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis.

Juvenile Idiopathic Arthritis Clinical Trial using tocilizumab [RoActemra/Actemra]

Hoffmann-La Roche - Recruiting 2 years to 17 years.
- A Phase IV Study to Evaluate Decreased Dose Frequency in Patients With Systemic Juvenile Arthritis (SJIA) Who Experience Laboratory Abnormalities During Treatment With Tocilizumab.
tocilizumab [RoActemra/Actemra]

Juvenile Idiopathic Arthritis Clinical Trial using CP-690,550

Pfizer - Recruiting 2 years to 18 years.
- An Open-Label Multiple Dose Study To Evaluate The Pharmacokinetics, Safety And Tolerability Of CP-690,550 In Pediatric Patients From 2 To Less Than 18 Years Of Age With Juvenile Idiopathic Arthritis (JIA).
CP-690,550

Arthritis, Juvenile Rheumatoid Clinical Trial using Sulfasalazine

Pfizer - Recruiting 6 years to 17 years.
- An Open Label Non-Randomized Study To Characterize The Steady State Pharmacokinetics Of Sulfasalazine Delayed Release Tablets In Children With Juvenile Idiopathic Arthritis.
Sulfasalazine

Juvenile Idiopathic Arthritis Clinical Trial using Web-based coping skills training; Online disease education

Children's Mercy Hospital Kansas City - Recruiting 12 years to 18 years.
- WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis.
Web-based coping skills training; Online disease education

Juvenile Idiopathic Arthritis Clinical Trial using RoActemra/Actemra (tocilizumab)

Hoffmann-La Roche - Recruiting 2 years or older.
- Long-term, Interventional, Open Label Extension Study Evaluating the Safety of Tocilizumab Treatment in Patients With Polyarticular-course Juvenile Idiopathic Arthritis From Poland and Russia Who Completed the Global, Multinational Trial (WA19977)..
RoActemra/Actemra (tocilizumab)

Juvenile Idiopathic Arthritis, Rheumatoid Arthritis Clinical Trial using Tocilizumab [RoActemra/Actemra]

Hoffmann-La Roche - Recruiting N/A to 24 Months.
- A Phase I Pharmacokinetic and Safety Study of Tocilizumab (TCZ) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA).
Tocilizumab [RoActemra/Actemra]

Arthritis, Juvenile Rheumatoid Clinical Trial

AbbVie - Recruiting N/A or older.
- Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis.

Juvenile Idiopathic Arthritis Clinical Trial using Blood test

Assistance Publique - H“pitaux de Paris - Recruiting 4 years to 17 years.
- Determination of the Effective Individual Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis.
Blood test

Juvenile Idiopathic Arthritis Clinical Trial using Virtual Peer-to-Peer Support Mentoring

The Hospital for Sick Children - Recruiting 12 years to 18 years.
- Virtual Peer-to-Peer Support Mentoring for Adolescents With Juvenile Idiopathic Arthritis: A Feasibility Pilot Randomized Controlled Trial.
Virtual Peer-to-Peer Support Mentoring

Juvenile Idiopathic Arthritis Clinical Trial using Abatacept

Bristol-Myers Squibb - Recruiting 4 years to 17 years.
- A Phase III, Multicenter, Open-Label Study to Assess Efficacy, Safety, Pharmacokinetics and Immunogenicity of Abatacept Administered Intravenously in Japanese Children and Adolescents With Active Juvenile Idiopathic Arthritis Who Have a History of an Inadequate Response or Intolerance to Methotrexate or Biologics.
Abatacept

Juvenile Idiopathic Arthritis Clinical Trial using intra-articular steroid injection

University Hospital Tuebingen - Recruiting 7 years to 17 years.
- Diagnostic Value of MRI and Ultrasound in Patients With JIA.
intra-articular steroid injection